The best practice is to adhere to the recommended 30-day refrigerated shelf life and discard any unused solution after that period
50,53,54 In population pharmacokinetic models using data from trials with oral or subcutaneous administration of semaglutide, body weight had an effect on semaglutide pharmacokinetics, which did not warrant dose adjustment
Serial dilutions of unfused albumin variants (0.034375.2 nM) or GLP-1 albumin fusions (0.031368.5 nM) (100 L/well), diluted in PBS/T/M (pH 5.5 or pH 7.4), were added for 1 h at room temperature
rapid dose increases often worsen symptoms Discuss with your clinician about temporarily slowing dose escalation, reducing dose or potential gap if symptoms are intolerable When to seek medical advice Contact your healthcare provider immediately if you experience: Inability to keep any fluids down for more than 24 hours Signs of dehydration (extreme thirst, dark urine, dizziness) Vomiting blood or material that resembles coffee grounds Severe or persistent abdominal pain Fever accompanying vomiting Symptoms that severely impact your quality of life despite management strategies Long-term outlook For most GLP-1 patients, nausea and vomiting are temporary side effects that become more manageable as their bodies adjust to the medication
In Global Health policy, the World Health Organisation (WHO) issued its first global guideline on the use of GLP-1 medicines in treating obesity in December 2025
.png)
